Product Images Relistor

This appears to be a table with data on various treatments and their effectiveness for patients. Not enough context is given to determine what condition or illness is being treated.*

This is a diagram of different parts of a vial and syringe, including a cap, rubber stopper, plunger, needle, and barrel needle cap. The figure A shows a retractable needle plunger.*

This appears to be a diagram or image of parts related to vials and syringes. The text indicates various components, including a rubber stopper, top of the plunger, barrel, needle cap, and retractable needle. The image shows a labeled diagram with these parts identified. No additional information or context is available.*

The text appears to be a technical instruction for administering medication through a syringe. It describes how to align the plunger with the 0.4 mL dose mark on the syringe barrel. The text is accompanied by a figure demonstrating the correct alignment.*

Not available.*

This is a description of a medication called RELISTOR containing pre-filled syringes of methylnaltrexone bromide for subcutaneous injection. The package includes seven syringes and four inserts with prescribing information, instructions, and a medication guide. Each syringe contains 12 mg of methylnaltrexone bromide, sodium chloride, edstate calcium disodium, and glycine hydrochloride. Dosage and administration may vary by patient weight. The medication should be kept at controlled room temperature and should not be frozen. The medication is manufactured by Progenics Pharmaceutical and is a trademark of Salix Pharmaceuticals. A pharmacist should dispense the medication guide to each patient.*

The text describes a package containing seven pre-filled syringes of RELISTOR® (methylnaltrexone bromide) Subcutaneous Injection for administration in patients. Each syringe contains 8 mg of methylnaltrexone bromide in 0.4 mL of water, and the dose may vary by patient weight. The package insert contains dosage and administration instructions, prescribing information, and a medication guide. The medication should be kept out of the reach of children and stored between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The medication should not be frozen, and it is distributed by Salix.*

The text describes a pre-filled syringe with parts including a syringe barrel, a needle cap, a needle guard, a plunger, and a needle. The image labeled "Figure A" may illustrate these parts.*